Clinically, identifying emotion recognition deficits in women with PCOS may inform early psychotherapeutic or pharmaceutical intervention strategies (e.g., androgen receptor antagonists23) aimed at improving emotion regulation and social functioning, and reducing the risk of mood disorders in this group. The gene discussed is AR; the disease is polycystic ovary syndrome.